Avadel Pharmaceuticals plc (NASDAQ:AVDL)

CAPS Rating: 3 out of 5

A biopharmaceutical company principally engaged in the development of two unique polymer-based drug delivery technologies for the improvement of medical applications.

Caps

How do you think AVDL will perform against the market?

Add Stock to CAPS Watchlist

All Players

334 Outperform
24 Underperform
 

All-Star Players

82 Outperform
10 Underperform
 

Wall Street

3 Outperform
1 Underperform
 

Top AVDL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

zzlangerhans (99.70)
Submitted January 03, 2016

Whenever I start thinking I screwed up absolutely every trade in 2015, I just go back and look at my Tweets on Flamel during the year. While my price points weren't ideal, I still managed to tranche trade the stock for strong profits and dumped my… More

OOji (28.20)
Submitted May 18, 2008

Investing is a risky proposition.

AVDL VS S&P 500 (SPY)

Fools bullish on AVDL are also bullish on:

Fools bearish on AVDL are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about AVDL.

Recs

0
Member Avatar EBITKing (28.86) Submitted: 12/15/2017 11:02:10 AM : Outperform Start Price: $8.69 AVDL Score: -28.07

Operating Income after Depr. / Ent. Value = 39%

Recs

1
Member Avatar zzlangerhans (99.70) Submitted: 1/2/2016 9:40:30 PM : Outperform Start Price: $12.34 AVDL Score: -80.12

Whenever I start thinking I screwed up absolutely every trade in 2015, I just go back and look at my Tweets on Flamel during the year. While my price points weren't ideal, I still managed to tranche trade the stock for strong profits and dumped my last bloc close to the year highs. Then I watched my Flamel profits remain solid near the top of the zzporte gains list as the stocks we held on to slipped into the swamp. I haven't trusted the stock since it plunged about 50% intraday on approval of a competitor's generic neostigmine a year ago. I bought on that dip and was lucky to escape when the stock rebounded, but my skepticism about long-term strength seems to have been well-founded. The latest smack to the stock came in the last trading session of the year, when the stock plummeted from 14's to 12 on word of approval of a second competing neostigmine generic.

The truth is, it is very difficult to model Flamel's future revenues from the Eclat generic pipeline, and their legacy Micropump/Medusa platform remains as dubious and opaque as ever. Flamel has a new PDUFA for an unspecified Eclat generic on April 26, and they've had a very good although not spotless record with the FDA thus far. That makes Flamel tempting for a new zzporte position given our prior success with the stock, but lately I've been trying to move away from positions at risk for surprising buzzcuts. In addition, our attempts to replicate prior successes with the same stocks haven't typically gone well. For that reason, I think Flamel is going to remain a CAPS-only play for the time being.

Recs

0
Member Avatar kaunas7 (26.21) Submitted: 4/28/2015 9:33:23 PM : Outperform Start Price: $14.50 AVDL Score: -85.06

Starting to become very profitable and looking good for 2016 as well.

Leaderboard

Find the members with the highest scoring picks in AVDL.

Score Leader

Chemnerd

Chemnerd (68.42) Score: +503.02

The Score Leader is the player with the highest score across all their picks in AVDL.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
gabenell 91.27 8/28/2006 Underperform 3M $17.00 -61.94% +124.28% +186.22 0 Comment
BSUvsOU 95.73 8/28/2006 Underperform 3Y $17.00 -61.94% +123.26% +185.20 0 Comment
Gallizon 63.21 8/28/2006 Underperform 1Y $16.97 -61.87% +123.27% +185.15 0 Comment
ozarksmart < 20 12/26/2006 Underperform 1Y $30.50 -78.79% +105.63% +184.42 0 Comment
zynergy < 20 12/14/2006 Underperform 3W $32.31 -79.98% +104.11% +184.09 0 Comment
shire1 < 20 10/17/2006 Underperform 3M $22.83 -71.66% +112.38% +184.04 0 Comment
petercalon 89.68 9/18/2006 Underperform 1Y $18.00 -64.06% +119.74% +183.79 0 Comment
DoctorBob48 < 20 11/30/2006 Underperform 1Y $28.55 -77.34% +106.22% +183.56 1 Comment
tfl888 < 20 9/25/2006 Underperform 1Y $17.83 -63.71% +119.80% +183.51 0 Comment
rseeleyco2 < 20 11/22/2006 Underperform 1Y $28.67 -77.43% +105.57% +183.00 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackSunTrustRH 87.80 3/18/2014 Outperform NS $11.76 -44.98% +46.11% -91.09 0 Comment
TrackLadenburg < 20 11/5/2008 Outperform NS $7.06 -8.36% +182.13% -190.48 0 Comment
trackmerriman 68.92 1/29/2008 Outperform NS $9.97 +7.52% +3.44% +4.08 6/5/2008 @ $10.72 0 Comment
TrackEveillard 96.29 9/30/2007 Outperform NS $8.99 +11.01% -4.17% +15.19 12/31/2007 @ $9.98 1 Comment
TrackEinhorn 95.79 9/30/2007 Outperform NS $8.99 -8.01% -16.48% +8.47 8/27/2008 @ $8.27 2 Comments
TrackRodmanRen < 20 6/29/2007 Outperform NS $21.90 -70.46% +90.06% -160.51 0 Comment
TrackPZK < 20 10/23/2006 Outperform NS $23.10 -77.45% +0.97% -78.41 4/17/2012 @ $5.21 0 Comment
TrackJimCramer 85.39 10/18/2006 Underperform 3W $22.62 -71.40% +110.97% +182.37 0 Comment
trackmerriman 68.92 10/11/2006 Outperform NS $19.65 -18.32% +9.23% -27.55 8/3/2007 @ $16.05 0 Comment

Featured Broker Partners